4-9-2021Cross-posted from NIAID NewsroomThe COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevent…
2-19-2021For social media: NIH-funded researchers and others report on US efforts to end the #HIV epidemic in @TheLancet, calling for #HealthDisparities to be addressed.…
1-26-2021#HIVPrevention NEWS from @NIAIDnews: Infusions of an anti-HIV #antibody prevented acquisition of #HIV strains sensitive to that antibody, but did not significan…
12-3-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and Infec…
11-9-2020Cross-posted from NIAID NewsroomLong-Acting Regimen More Effective than Daily Oral Pill Among African WomenA pre-exposure prophylaxis (PrEP) regimen containing …
7-24-2020Cross-posted from NIAID NewsroomNIAID Celebrates Pivotal Step Toward Expanding HIV Prevention Choices for WomenToday the European Medicines Agency (EMA) announc…
7-24-2020Cross-posted from NIAID NewsroomMulticenter HOPE Act Study Expands Pool of Available KidneysKidney transplantation from deceased donors with HIV to people livin…
7-21-2020Cross-posted from NIAID NewsroomThe National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and IAVI, a nonprofit scie…
7-7-2020Cross-posted from NIAID NewsroomBoth Methods Highly Effective at Preventing HIV Among Men Who Have Sex with Men and Transgender WomenA pre-exposure prophylaxis …
5-18-2020Cross-posted from NIAID NewsroomNIH Study is First Large Trial to Find Long-Acting HIV Prevention Highly Effective--Companion Study in Women Is OngoingAn invest…
